• Improving Public Health Through Drug Monitoring

    Clinical Research News | From a regulatory point of view, detailed and complete monitoring and reporting of adverse events and other drug problems has been recognized as the best way to build a strong, sustainable system for medicine safety and for public confidence in medicines.

    Dec 10, 2021

  • PCORI Approves Funding For mHealth, CARES Trial, More

    Clinical Research News | The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved two slates of research funding awards totaling $49.5 million to support nine new comparative clinical effectiveness research (CER) studies aimed at improving care for adults and children across a range of health conditions.

    Dec 8, 2021

  • Follow the Money: 3D Telepresense, Transplant Rejection Trials

    Clinical Research News | Clinical trials for lung transplant rejection and sickle cell disease, immersive 3D telepresense for remote patient engagement, and precision dosing technology.

    Dec 2, 2021

  • Engaging Risk-Based Quality Monitoring Teams Through Role-Playing

    Clinical Research News | Most pharmaceutical companies today have a dedicated team for risk-based quality management (RBQM) whose job it is to imagine the many ways clinical trials could go wrong to prevent their failure. Gone are the days when averting risk was largely an exercise in source data verification based on the perceived difficulty in study execution, says Marcin Makowski, M.D., Ph.D., head of centralized monitoring and data analytics at GlaxoSmithKline (GSK).

    Dec 1, 2021

  • Roche Announces IMPACT Trial Results, RWE Acquisitions, More

    Clinical Research News | Acquisitions for THREAD, Elsevier, and Global Healthcare Opportunities. Partnerships for international trials and AI-based clinical trial acceleration software. Plus new products from Intuity Medical, Florence, uMotif, and more.

    Nov 30, 2021

  • (Clinical) Trial or Error: The Modernization of Respiratory Clinical Trials

    Clinical Research News | Historically, clinical trials are slow and costly, and of all therapeutic areas, none is more expensive than respiratory trials. How can the pulmonary field that is still struggling to cope with COVID-19, massive wildfires, and the epidemic of lung injury due to vaping, meet the critical need for accelerated drug development and improved clinical care? The answer must come directly from investigators and clinicians doing the work, applying technology in new ways based on what they’ve learned.

    Nov 23, 2021